Bifidobacterium lactis inhibits NF-κB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice

Inflammatory Bowel Diseases

Volumn 16, Issue 9, 2010, Pages 1514-1525

  Kim, Seung Won ^a   Kim, Hee Man ^a   Yang, Kyoung Min ^a   Kim, Sun Ah ^b   Kim, Sung Kyu ^b   An, Min Ji ^a   Park, Jae Jun ^a   Lee, Sang Kil ^a   Kim, Tae Il ^a   Kim, Won Ho ^a   Cheon, Jae Hee ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Nutra R and BT   (South Korea)

Author keywords

Bifidobacterium lactis; Colitis; Colitis associated colon cancer; Inflammatory bowel disease; Nuclear factor kappa B

Indexed keywords

AZOXYMETHANE; DEXTRAN SULFATE; GENE PRODUCT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE COLITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIFIDOBACTERIUM ANIMALIS; BINDING AFFINITY; CANCER GROWTH; CANCER PREVENTION; CANCER SIZE; CELL STRAIN HT29; CLINICAL ASSESSMENT; COLITIS; COLON CANCER; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REPORTER GENE; SCORING SYSTEM; SIGNAL TRANSDUCTION;

ACUTE DISEASE; ANIMALS; AZOXYMETHANE; BIFIDOBACTERIALES INFECTIONS; BIFIDOBACTERIUM; BLOTTING, WESTERN; CARCINOGENS; CHRONIC DISEASE; COLITIS; COLON; COLONIC NEOPLASMS; DEXTRAN SULFATE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; LUCIFERASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77956275992     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21262     Document Type: Article

References (43)

1. Potack J, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease. Gut Liver. 2008;2:61-73
2. Lewis JD, Deren JJ, Lichtenstein GR. Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:459-477. (Pubitemid 29306488)
3. Bonizzi G, Piette J, Merville MP, et al. Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells. J Immunol. 1997;159:5264-5272. (Pubitemid 127470052)
4. De Plaen IG, Tan XD, Chang H, et al. Lipopolysaccharide activates nuclear factor kappa B in rat intestine: role of endogenous platelet activating factor and tumour necrosis factor. Br J Pharmacol. 2000;129:307-314. (Pubitemid 30072651)
5. Li Q, Verma IM. NF-κB regulation in the immune system. Nat Rev Immunol. 2002;2:725-734.
6. Neish AS. Molecular aspects of intestinal epithelial cell-bacterial interactions that determine the development of intestinal inflammation. Inflamm Bowel Dis. 2004;10:159-168.
7. Jobin C, Sartor RB. NF-κB signaling proteins as therapeutic targets for inflammatory bowel diseases. Inflamm Bowel Dis. 2000;6:206-213.
8. Pikarsky E, Porat RM, Stein I, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431:461-466. (Pubitemid 39329586)
9. Yu HG, Zhong X, Yang YN, et al. Increased expression of nuclear factor-kappaB/RelA is correlated with tumor angiogenesis in human colorectal cancer. Int J Colorectal Dis. 2004;19:18-22. (Pubitemid 38088281)
10. Karin M, Cao Y, Greten FR, et al. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301-310. (Pubitemid 37328783)
11. Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285-296. (Pubitemid 39061110)
12. Otte JM, Cario E, Podolsky DK. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology. 2004;126:1054-1070. (Pubitemid 38451177)
13. Petrof EO, Kojima K, Ropeleski MJ, et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology. 2004;127:1474-1487. (Pubitemid 39457773)
14. Sheil B, McCarthy J, O'Mahony L, et al. Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut. 2004;53:694-700. (Pubitemid 38561448)
15. Wollowski I, Rechkemmer G, Pool-Zobel BL. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr. 2001;73:451S-455S. (Pubitemid 32114158)
16. Reuter G. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol. 2001;2:43-53. (Pubitemid 33061768)
17. Imaoka A, Shima T, Kato K, et al. Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol. 2008;14:2511-2516. (Pubitemid 352037738)
18. Reddy BS, Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5- f]quinoline, a food mutagen. Cancer Res. 1993;53:3914-3918.
19. Nam SY, Kim JS, Kim JM, et al. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis. Exp Biol Med (Maywood). 2008;233:180-191.
20. Cheon JH, Kim JS, Kim JM, et al. Plant sterol guggulsterone inhibits NF-κB signaling in intestinal epithelial cells by blocking IκB kinase and ameliorates acute murine colitis. Inflamm Bowel Dis. 2006;12:1152-1161.
21. O'Hara AM, O'Regan P, Fanning A, et al. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology. 2006;118:202-215. (Pubitemid 43727425)
22. Kumar A, Wu H, Collier-Hyams LS, et al. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J. 2007;26:4457-4466. (Pubitemid 350036625)
23. Kucharczak J, Simmons MJ, Fan Y, et al. To be, or not to be: NF-kappaB is the answer - role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene. 2003;22:8961-8982. (Pubitemid 38121698)
24. Riedel CU, Foata F, Philippe D, et al. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World J Gastroenterol. 2006;12:3729-3735. (Pubitemid 43950950)
25. Peran L, Camuesco D, Comalada M, et al. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. J Appl Microbiol. 2007;103:836-844. (Pubitemid 47493215)
26. Lee H, Ahn YT, Lee JH, et al. Evaluation of anti-colitic effect of lactic acid bacteria in mice by cDNA microarray analysis. Inflammation. 2009;32:379-386.
27. Ruiz PA, Hoffmann M, Szcesny S, et al. Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology. 2005;115:441-450. (Pubitemid 41032432)
28. Moran JP, Walter J, Tannock GW, et al. Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice. Inflamm Bowel Dis. 2009;15:1022-1031.
29. Chen LW, Egan L, Li ZW, et al. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med. 2003;9:575-581. (Pubitemid 36597104)
30. Karrasch T, Kim JS, Jang BI, et al. The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB(EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules. PLoS One. 2007;2:e596.
31. Egan LJ, Eckmann L, Greten FR, et al. IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci U S A. 2004;101:2452-2457. (Pubitemid 38269332)
32. Weber CK, Liptay S, Wirth T, et al. Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology. 2000;119:1209-1218.
33. Nurmi JT, Puolakkainen PA, Rautonen NE. Bifidobacterium Lactis sp. 420 up-regulates cyclooxygenase (Cox)-1 and down-regulates Cox-2 gene expression in a Caco-2 cell culture model. Nutr Cancer. 2005;51:83-92.
34. Moore AE, Greenhough A, Roberts HR, et al. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells. Carcinogenesis. 2009;30:1796-1804
35. Takahashi Y, Kitadai Y, Bucana CD, et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 1995;55:3964-3968.
36. Fukutake M, Nakatsugi S, Isoi T, et al. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis. 1998;19:1939-1942. (Pubitemid 28521934)
37. Kohno H, Suzuki R, Sugie S, et al. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer. 2005;5:46.
38. Singer, II, Kawka DW, Schloemann S, et al. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology. 1998;115:297-306. (Pubitemid 28363422)
39. Wang D, Mann JR, DuBois RN. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology. 2005;128:1445-1461. (Pubitemid 40712194)
40. Nurmi JT, Puolakkainen PA, Rautonen NE. Bifidobacterium lactis sp. 420 up-regulates cyclooxygenase (Cox)-1 and down-regulates Cox-2 gene expression in a Caco-2 cell culture model. Nutr Cancer. 2005;51:83-92.
41. Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem. 2002;277:50959-50965. (Pubitemid 36042264)
42. Korhonen R, Kosonen O, Korpela R, et al. The expression of COX2 protein induced by Lactobacillus rhamnosus GG, endotoxin and lipoteichoic acid in T84 epithelial cells. Lett Appl Microbiol. 2004;39:19-24. (Pubitemid 38869803)
43. Morteau O, Morham SG, Sellon R, et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest. 2000;105:469-478. (Pubitemid 30127247)